2016-03-14T00:00:00.000-04:00
analysts,0.495612
synthetic fatty-acid/bile-acid conjugate,-0.46281
treatment,-0.46281
clinical-stage biopharmaceutical company,0.260403
email newsletter,0.562009
Galmed Pharmaceuticals Ltd.,0.260403
new 52-week low,-0.560764
Monday,-0.257223
Pharmaceuticals Ltd Daily,0.353397
email address,0.495612
related companies,0.562009
InvestorPlace Broker Center,0.555736
MarketBeat Ratings reports,-0.37267
average price target,-0.384957
high fees,-0.735674
sell rating,0.436676
personal trading style,0.598412
investment analyst,0.436676
glance,0.51306
average rating,-0.396952
latest news,0.495612
buy rating,0.436676
cholesterol gallstones,-0.46281
oral therapy,-0.46281
Galmed Pharmaceuticals,-0.0118787
shares,0.37478
liver diseases,-0.46281
concise daily summary,0.495612
stock broker,0.245696
